Please upgrade your browser.
What is a kidney cyst and should I worry about kidney cancer? Should I have this cyst removed?
The latest news related to kidney cancer, courtesy of the Kidney Cancer Association's electronic news clipping service.
Papillary renal cell carcinoma may display some unusual morphologic variations, including diffuse oncocytic change not otherwise specified, oncocytic change associated with an inverted nuclear pattern or nonoverlapping low-grade nuclei, low-grade spindle cells, and diffuse clear cells.
Educating the public, residents and referring physicians about radiation exposure and associated risk took a step forward with the creation of the new iPhone application, Radiation Passport.
Patients with advanced renal cell carcinoma who responded to angiogenesis inhibitor drugs also had higher hemoglobin levels, a researcher reported in a poster at the ASH 51st Annual Meeting, in New Orleans, Louisiana.
Kidney Cancer News is our periodical for patients, survivors, and others with an interest in kidney cancer. Subscribe here. If you are a registered user on this website, you'll receive this publication automatically. If not, click "Subscribe here" to create an account. FREE registration brings many benefits, including access to our online Forum for survivors and their families--more than 3,000 members strong, much bigger than any email listserve, and the largest virtual community of its kind!
In a trial to ascertain the risk of developing bilateral kidney cancer, it was concluded that the risk of metachronous bilateral renal cell cancer (RCC) is drastically higher among pts first affected at a young age, suggesting a subset of early onset RCC with a strong genetic component.
CHICAGO -- Almost all patients with papillary renal carcinoma had stable disease or better response to treatment with a drug that targets multiple growth factors, preliminary data from an ongoing trial showed. Daily and intermittent dosing with foretinib resulted in a total clinical benefit greater than 90%, according to researchers here at the International Kidney Cancer Symposium.
|Powered by NeonCRM|